Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form
- PMID: 2065254
- DOI: 10.1093/brain/114.3.1335
Neurological disease in xeroderma pigmentosum. Documentation of a late onset type of the juvenile onset form
Abstract
Xeroderma pigmentosum (XP) is an autosomal recessive, neurocutaneous disorder characterized by sunlight-induced skin cancers and defective DNA repair. Many XP children develop a primary neuronal degeneration. We describe 2 unusual XP patients who had a delayed onset of XP neurological disease. Somatic cell genetic studies indicated that they have the same defective DNA repair gene and are both in XP complementation group A. These 2 patients, together with a group A patient previously reported from London, establish as a distinct clinical entity the late onset type of the juvenile onset form of XP neurological disease. The functional capacity of these patients' cultured fibroblast strains to survive after treatment with ultraviolet radiation indicates that their DNA repair defect is less severe than that of typical group A patients who have a more severe neurodegeneration with an earlier symptomatic onset. The premature death of nerve cells in XP patients (which is presumably due to their inherited defects in DNA repair mechanisms) suggests that normal repair of damaged DNA in neurons is required to maintain integrity of the human nervous system.
Similar articles
-
Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.Proc Natl Acad Sci U S A. 1978 Apr;75(4):1984-8. doi: 10.1073/pnas.75.4.1984. Proc Natl Acad Sci U S A. 1978. PMID: 273925 Free PMC article.
-
Enzyme defects in xeroderma pigmentosum.J Dermatol. 1976 Aug;3(4):163-70. doi: 10.1111/j.1346-8138.1976.tb01838.x. J Dermatol. 1976. PMID: 15633972
-
Evidence that lack of deoxyribonucleic acid repair causes death of neurons in xeroderma pigmentosum.Ann Neurol. 1983 Jun;13(6):682-4. doi: 10.1002/ana.410130621. Ann Neurol. 1983. PMID: 6881931
-
[Xeroderma pigmentosum].Nihon Rinsho. 2000 Jul;58(7):1496-500. Nihon Rinsho. 2000. PMID: 10921330 Review. Japanese.
-
Shining a light on xeroderma pigmentosum.J Invest Dermatol. 2012 Mar;132(3 Pt 2):785-96. doi: 10.1038/jid.2011.426. Epub 2012 Jan 5. J Invest Dermatol. 2012. PMID: 22217736 Free PMC article. Review.
Cited by
-
Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.PLoS Genet. 2010 Mar 5;6(3):e1000871. doi: 10.1371/journal.pgen.1000871. PLoS Genet. 2010. PMID: 20221251 Free PMC article.
-
Neuroimaging features of xeroderma pigmentosum group A.Brain Behav. 2012 Jan;2(1):1-5. doi: 10.1002/brb3.22. Brain Behav. 2012. PMID: 22574268 Free PMC article.
-
Nucleotide excision repair and cancer.J Mol Histol. 2006 Sep;37(5-7):225-38. doi: 10.1007/s10735-006-9041-x. Epub 2006 Jul 20. J Mol Histol. 2006. PMID: 16855787 Review.
-
Different germline variants in the XPA gene are associated with severe, intermediate, or mild neurodegeneration in xeroderma pigmentosum patients.PLoS Genet. 2024 Dec 2;20(12):e1011265. doi: 10.1371/journal.pgen.1011265. eCollection 2024 Dec. PLoS Genet. 2024. PMID: 39621777 Free PMC article.
-
Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.Surv Ophthalmol. 2011 Jul-Aug;56(4):348-61. doi: 10.1016/j.survophthal.2011.03.001. Surv Ophthalmol. 2011. PMID: 21684361 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials